NuCana (NCNA) Receivables - Other (2016 - 2024)

NuCana's (NCNA) quarterly Receivables - Other came in at $23103.0 in Q4 2024, up 3.41% year-on-year from $22340.7 in Q1 2024, and up 3.41% quarter-over-quarter from $22340.7 in Q4 2023.

NuCana (NCNA) Receivables - Other (2016 - 2024) Analysis & Trends

NuCana has disclosed Receivables - Other across 9 years of filings, most recently posting $23103.0 for Q4 2024.

  • Receivables - Other for Q4 2024 came in at $23103.0, up 3.41% year-over-year; the trailing twelve-month figure through Dec 2024 was $23103.0 (up 3.41% YoY), and the FY2024 annual result was $23009.0, up 2.77% from the prior year.
  • Receivables - Other came in at $23103.0 for Q4 2024 at NuCana, up from $22340.7 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $23103.0 in Q4 2024 to a low of $11884.1 in Q4 2020.
  • The 5-year median for Receivables - Other is $16421.0 (2022), against an average of $17176.2.
  • Across the five-year window, Receivables - Other plunged 76.89% in 2020 and surged 36.05% in 2023, its largest moves.
  • NuCana's Receivables - Other stood at $11884.1 in 2020, then grew by 2.09% to $12132.1 in 2021, then jumped by 35.35% to $16421.0 in 2022, then jumped by 36.05% to $22340.7 in 2023, then rose by 3.41% to $23103.0 in 2024.
  • The last three Receivables - Other figures came in at $23103.0 (Q4 2024), $22340.7 (Q4 2023), and $16421.0 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 NuCana 29.13 Bn 29.13 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 23,103.03
Dec 31, 2024 23,103.03
Dec 31, 2023 22,340.73
Dec 31, 2023 22,340.73
Dec 31, 2022 16,421.00
Dec 31, 2022 16,421.00
Dec 31, 2021 12,132.10
Dec 31, 2021 12,132.10
Dec 31, 2020 11,884.06
Dec 31, 2020 11,884.06
Dec 31, 2019 51,429.00
Dec 31, 2019 51,429.00
Dec 31, 2018 12,867.67
Dec 31, 2018 12,867.67
Dec 31, 2017 11,948.98
Dec 31, 2017 11,948.98
Dec 31, 2016 238,698.67
Dec 31, 2016 238,698.67